<<Google’s new venture capital arm is making its first investment in biotechnology. It is putting an undisclosed amount of money — but probably around $10 million — into Adimab, a company with a novel method of generating protein-based drugs.>>
<<Adimab’s technology, developed by scientists at Dartmouth and M.I.T., can help pharmaceutical companies find effective monoclonal antibodies, which are genetically engineered versions of proteins the body makes to latch onto invading pathogens. Some of the most successful drugs, like the cancer drug Avastin and the rheumatoid arthritis drug Humira, are monoclonal antibodies.>>
http://bits.blogs.nytimes.com/2009/10/01/googles-venture-arm-invests-in-biotech-start-up/ |
[moved from "Google Venture invests in Adimab company"]
http://sanjose.bizjournals.com/sanjose/mobile/stories/2009/09/28/daily67.html |